Chocobo GP is coming exclusively to Nintendo Switch in 2022. A trailer was shown in today's Nintendo Direct, showing off courses, characters, karts, and more. The Final Fantasy spinoff racing game ...

For whatever reason, these Final Fantasy games were at least in some stage of development before being shelved — although ...

Toshiyuki Itahana, a character designer who worked on Final Fantasy 9, has left Square Enix, further dashing hopes that we ...

Following the celebrated JRPG's 25th anniversary, Final Fantasy IX character designer Toshiyuki Itahana has departed Square ...

How to access virtual and in-person private GP appointments, costs compared, and what to know about private vs NHS GPs Megan ThomasResearcher & writer Senior researcher and writer at Which?, focusing ...

Ireland is attracting major investment from the largest pharma companies in the world. Ben Hargreaves finds out how the country has become one of the most significant locations in Europe for ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

Six years between crowns and becoming the benchmark once again - here's the story of 2025 to complete greatest comeback in sport ...

Joined by mum Belinda and stepdad Justin, Campbell shares his story as he spends a memorable Phillip Island weekend surrounded by the MotoGP stars Alberto Puig shares his thoughts on a transformative ...

The Grand Prix Cycliste de Montréal, along with its sister race the Grand Prix Cycliste de Québec, are currently the only two WorldTour races held in North America. The Grand Prix Cycliste de Montréal ...

The Grand Prix Cycliste de Québec returns for a 15th edition on September 12, 2026. The race began in 2010 and was upgraded the next year to the top level, where it has remained. Only twice has the ...

AnaptysBio seeks partial dismissal in GSK oncology unit dispute over drug royalty AnaptysBio said on Thursday it filed a partial motion to dismiss a claim by GSK's oncology unit, which alleges the ...